Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. is a scientific skincare company focused on developing and commercializing treatments for common and underserved dermatological conditions, such as acne. The company is shifting its strategic focus from prescription pharmaceuticals toward science-backed, direct-to-consumer and professional business-to-business skincare lines, branded as Tome. Its planned product portfolio includes foundational topical treatments and over-the-counter acne systems utilizing a purified freshwater sponge powder known as Spongilla lacustris, or Bioneedle, combined with active ingredients like salicylic acid. Beyond topical acne solutions, the company explores applications for its microstructure technology to facilitate intradermal delivery of aesthetic treatments.

The company's primary target market includes consumers seeking over-the-counter skin wellness products as well as dermatologists and aesthetic healthcare professionals. Dermata operates from its principal executive offices located in San Diego, California. The text does not report retail store locations or international business figures.

Summary of the business section of Dermata Therapeutics's latest annual report, written by StockData.

“As of the date of this report, we have nine full-time employees, with four employees working in the selling, general and administrative department, two engaged in non-clinical and clinical development, two working in the chemistry, manufacturing, and controls department, and one employee working in the regulatory affairs and quality control department.”